SEC Filing Summary: Capital Product Partners L.P. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Capital Product Partners L.P., a foreign private issuer, for the month of June 2016. The filing, dated June 3, 2016, serves to distribute a press release and materials related to the 2016 Annual General Meeting of Limited Partners. The registrant's principal executive offices are located in Piraeus, Greece.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute corporate governance materials and a press release rather than a financial statement.
Material Changes
No material financial changes versus prior periods are detailed in this specific filing text. The primary content relates to the scheduling and documentation for the annual meeting of limited partners.
Guidance, Outlook, and Corporate Actions
- Corporate Actions: The filing includes a letter to Limited Partners and a notice of the 2016 Annual General Meeting.
- Proxy Materials: Proxy cards for holders of common units and Class B Convertible Preferred Units are attached as exhibits.
- Exhibits: Exhibit I contains a press release dated June 3, 2016. Exhibits II, III, and IV are incorporated by reference into the registrant's Registration Statements on Form F-3.
- Management Commentary: The filing is signed by Gerasimos (Jerry) Kalogiratos, Chief Executive Officer and Chief Financial Officer of Capital GP L.L.C.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit I for specific operational or financial updates not summarized in the cover letter.
- Review the letter to Limited Partners (Exhibit II) for details on the agenda of the Annual General Meeting.
- Confirm the voting procedures and deadlines outlined in the Proxy Cards (Exhibits III and IV) for both common and Class B Convertible Preferred Unit holders.
- Check the referenced Form F-3 Registration Statements (File Nos. 333-210394 and 333-189603) for the full text of the incorporated exhibits.